Ticker League

EBITDA for CME Group (CME)

Latest filings through · Reported

Metric

TTM

$5.69B

YoY change

+13.5%

5Y CAGR

+11.3%

Peak year (2025)

$5.72B

EBITDA history chart for CME Group (CME) from 2000 to 2025

Latest: $5.72B

EBITDA growth chart for CME Group (CME) from 2000 to 2025

Latest: +13.5%

EBITDA history table for CME Group (CME) from 2000 to 2025

  • 2025$5.72B+13.5%
  • 2024$5.04B+8.0%
  • 2023$4.67B+16.2%
  • 2022$4.02B+2.3%
  • 2021$3.93B+17.1%
  • 2020$3.35B+0.4%
  • 2019$3.34B+4.9%
  • 2018$3.18B+11.7%
  • 2017$2.85B+8.2%
  • 2016$2.64B+14.5%
  • 2015$2.30B+8.4%
  • 2014$2.12B+6.7%
  • 2013$1.99B-4.2%
  • 2012$2.08B-10.2%
  • 2011$2.31B+9.1%
  • 2010$2.12B+16.3%
  • 2009$1.82B+14.5%
  • 2008$1.59B+30.6%
  • 2007$1.22B+75.1%
  • 2006$696.18M+27.5%
  • 2005$545.85M+32.4%
  • 2004$412.35M+59.1%
  • 2003$259.14M+15.2%
  • 2002$224.88M+39.3%
  • 2001$161.48M+535.6%
  • 2000$25.41M—

EBITDA values are taken from CME Group's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About EBITDA at CME Group (CME)

According to CME Group's latest reported financial statements, the company's current EBITDA (TTM) is $5.69B. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.

Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .

The 2025 reading of CME Group (CME) EBITDA is $5.72B – grew 13.5% year-over-year.

Through 2020–2025 (5 years), CME Group EBITDA delivered a +11.3% annualised rate; sustaining 12 straight years of year-over-year growth.

$5.72B stands as the all-time-high annual EBITDA, posted in 2025, against a low of $25.41M during 2000.

CME Group EBITDA by Year

CME Group EBITDA 2025: $5.72B

CME Group EBITDA in 2025 was $5.72B, grew 13.5% from 2024. This figure represents the highest annual value in the available history.

CME Group EBITDA 2024: $5.04B

2024's EBITDA for CME Group came in at $5.04B, grew 8.0% from 2023.

CME Group EBITDA 2023: $4.67B

CME Group posted EBITDA of $4.67B in 2023, grew 16.2% from 2022.

CME Group EBITDA 2022: $4.02B

In 2022, CME Group reported EBITDA of $4.02B, edged up 2.3% from 2021.

CME Group EBITDA 2021: $3.93B

CME Group EBITDA in 2021 was $3.93B.

See more financial history for CME Group (CME).

Sector peers by EBITDA

Financial Services peers of CME Group (CME), ranked by their latest EBITDA

Frequently asked questions

CME Group (CME) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation

Overview